Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug;106(2):1383-1400.
doi: 10.1002/ccd.31694. Epub 2025 Jun 19.

What Is the Role for TAVI in Failing Surgical Aortic Valves? A Review on Valve-in-Valve Interventions

Krupal Reddy  1   2 , Sara Malakouti  1   3 , Luis Augusto Palma Dallan  4 , Guilherme F Attizzani  4 , William W O'Neill  5 , Bernardo Cortese  1   3   4
Affiliations
Review

What Is the Role for TAVI in Failing Surgical Aortic Valves? A Review on Valve-in-Valve Interventions

Krupal Reddy et al. Catheter Cardiovasc Interv. 2025 Aug.

Abstract

Bioprosthetic surgical aortic valve failure represents a significant clinical challenge that necessitates timely and effective intervention to restore valve function and ensure patient well-being. Use of valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) has emerged as a feasible alternative to reoperation surgical aortic valve replacement (SAVR). By providing a less invasive option, this approach offers the opportunity to reduce the potential risks of a reoperation surgery. However, it is important to note that implementing ViV-TAVI requires careful preparation. This review outlines a thorough approach to ViV-TAVI, encompassing preprocedural planning, valve selection, implantation procedure, and its complications. With the availability of updated clinical data supporting long-term outcomes, this particular strategy is an excellent choice for the treatment of failed surgical aortic bioprostheses.

Keywords: BASILICA procedure; patient‐prosthesis mismatch; surgical aortic valve replacement (SAVR); transcatheter aortic valve implantation (TAVI); valve‐in‐valve transcatheter aortic valve implantation (ViV‐TAVI).

PubMed Disclaimer

References

    1. P. Wenaweser, L. Buellesfeld, U. Gerckens, and E. Grube, “Percutaneous Aortic Valve Replacement for Severe Aortic Regurgitation in Degenerated Bioprosthesis: The First Valve in Valve Procedure Using the Corevalve Revalving System,” Catheterization and Cardiovascular Interventions 70, no. 5 (2007): 760–764.
    1. S. Vemulapalli, J. D. Carroll, M. J. Mack, et al., “Procedural Volume and Outcomes for Transcatheter Aortic‐Valve Replacement,” New England Journal of Medicine 380, no. 26 (2019): 2541–2550.
    1. A. Vahanian, F. Beyersdorf, F. Praz, et al., “2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease,” European Heart Journal 43, no. 7 (2022): 561–632.
    1. C. M. Otto, R. A. Nishimura, R. O. Bonow, et al., “2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines,” Circulation 143, no. 5 (2021): e35–e71.
    1. R. Gurvitch, A. Cheung, J. Ye, et al., “Transcatheter Valve‐in‐Valve Implantation for Failed Surgical Bioprosthetic Valves,” Journal of the American College of Cardiology 58, no. 21 (2011): 2196–2209.

MeSH terms

LinkOut - more resources